ATS 2018 Efficacy, Safety of Dupilumab in Corticosteroid-Dependent Severe Asthma Publish Date May 21, 2018 Subcutaneous dupilumab significantly reduced the use of oral corticosteroids in patients with corticosteroid-dependent severe asthma.
